ADMA Biologics, Inc. (ADMA)
8.27
-0.23
(-2.71%)
USD |
NASDAQ |
May 15, 16:00
8.275
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Market Cap : 1.917B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 3.816B |
| Inovio Pharmaceuticals, Inc. | 106.96M |
| ACADIA Pharmaceuticals, Inc. | 3.664B |
| AnaptysBio, Inc. | 1.838B |
| Kodiak Sciences, Inc. | 2.317B |
Market Cap Related Metrics
| PE Ratio | 12.20 |
| PS Ratio | 3.962 |
| Price to Book Value | 4.911 |
| Price to Free Cash Flow | 18.78 |
| Price | 8.27 |
| Earnings Yield | 8.20% |
| Operating PE Ratio | 9.766 |
| Normalized PE Ratio | 12.03 |